Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05843201Not ApplicableCompleted

AquaPass Device in Treatment of CHF Patients

Role: lead

NCT06360380Not ApplicableRecruiting

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

Role: lead

NCT06401109Not ApplicableNot Yet Recruiting

Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European Registry

Role: lead

NCT06358365Not ApplicableCompleted

Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients

Role: lead

NCT04578353Not ApplicableCompleted

Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients

Role: lead

All 5 trials loaded